Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
Neuropsychiatr Dis Treat ; 11: 2833-6, 2015.
Article in English | MEDLINE | ID: mdl-26586947

ABSTRACT

Herpes simplex encephalitis is a rare disease. In adults, most of the reported cytomegalovirus (CMV) infections are seen in immunocompromised patients. We present a case of 67-year-old Chinese male with the coinfection of CMV and herpes simplex virus type II (HSV-II). He had no history of being treated with immunosuppressants, showed symptoms of psychosis and was scored 109 on the Positive and Negative Syndrome Scale. This patient presented with a rare case of coinfection of CMV and herpes simplex virus type II with psychotic symptoms.

2.
Biol Trace Elem Res ; 158(2): 211-8, 2014 May.
Article in English | MEDLINE | ID: mdl-24615552

ABSTRACT

We investigated the effect of zinc supplementation on the expression of metallothionein, lipid peroxidation (malondialdehyde, MDA), and poly(ADP-ribose) polymerase-1 (PARP-1) in the sciatic nerve, motor nerve conduction velocity of the left sciatic posterior tibial nerve in streptozotocin (STZ)-induced diabetic rats. Twenty-four male rats were equally divided into four groups. The first group served as untreated controls although the second group received 5 mg/kg/day zinc chloride. The third group was treated with STZ to induce diabetes, and the fourth group was treated with STZ and supplemented with zinc. A gradual but insignificant decline in motor nerve conduction velocity was observed at 2 weeks of induction of diabetes. Zinc supplementation markedly attenuated the decrease in motor nerve conduction velocity at week 8 post-induction of diabetes. Furthermore, the tactile response threshold of diabetic rats receiving normal saline was lower than that of diabetic rats receiving zinc supplementation. Additionally, zinc supplementation accentuated the increase in the mRNA transcript levels of metallothionein but attenuated the increase in the mRNA transcript levels of PARP-1. At week 8 post-induction of diabetes, diabetic rats receiving normal saline had markedly higher MDA contents than diabetic rats receiving zinc supplementation. In conclusion, the present study shows that zinc has a protective effect against diabetes-induced peripheral nerve damage by stimulating metallothionein synthesis and downregulating oxidative stress.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetic Neuropathies/drug therapy , Metallothionein/metabolism , Oxidative Stress/drug effects , Peripheral Nerves/drug effects , Up-Regulation/drug effects , Zinc/pharmacology , Animals , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/metabolism , Diabetic Neuropathies/chemically induced , Diabetic Neuropathies/metabolism , Dietary Supplements , Dose-Response Relationship, Drug , Male , Peripheral Nerves/metabolism , Rats , Rats, Sprague-Dawley , Streptozocin , Zinc/administration & dosage
3.
J Trauma ; 71(5): 1246-51, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22071926

ABSTRACT

OBJECTIVE: To explore a time-efficient method of identifying motor and sensory fascicles in peripheral nerve trunk. METHODS: Thirty Wistar rats were selected to obtain whole spine. The spinal dorsal roots and ventral roots, and sciatic nerve were harvested as sensor, motor, and mixed samples, annexin V and agrin specificities were observed with Western blot and immunohistochemistry. A total of 32 New Zealand rabbits were selected and killed. The roots of spinal nerves were exposed under an operating microscope, and the ventral and dorsal roots, ∼3 mm to 5 mm, were dissociated, and frozen as transverse sections of 30-µm thickness. The sections were examined by micro-Raman spectroscopy. RESULTS: The annexin V and agrin were special substances of sensory and motor nerves, respectively, and can act as specific antigens for identifying different nerve fascicles. Sections of the same type of nerve fascicles showed reproducibility with similar spectral features. Significant differences in the spectral properties, such as the intensity and breadth of the peak, were found between motor and sensory fascicles in the frequency regions of 1,088 cm(-1), 1,276 cm(-1), 1,439 cm(-1), 1,579 cm(-1), and 1,659 cm(-1). With the peak intensity ratio of 1.06 (I(1276)/I(1439)) as a standard, we could identify motor fascicles with a sensitivity of 88%, specificity of 94%, positive predictive value of 93%, and negative predictive value of 88%. In the range of 2,700 cm(-1) to 3,500 cm(-1), the half-peak width of the motor fascicles was narrow and sharp, whereas that of the sensory fascicles was relatively wider. A total of 91% of the peak features were in accordance with the identification standard. CONCLUSION: Motor and sensory fascicles exhibit different characteristics in Raman spectra, which are constant and reliable. Therefore, it is more effective than immunohistochemistry method in identifying different nerve fascicles according to the specific spectrum, and it possesses feasibility for clinical application.


Subject(s)
Peripheral Nerves/chemistry , Spectrum Analysis, Raman/methods , Spinal Nerve Roots/chemistry , Agrin/analysis , Animals , Annexin A5 , Blotting, Western , Immunoenzyme Techniques , Motor Neurons/chemistry , Nerve Fibers/chemistry , Rabbits , Rats , Rats, Wistar , Reproducibility of Results
4.
Arq Neuropsiquiatr ; 69(1): 105-11, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21359432

ABSTRACT

OBJECTIVE: Metallothionein 3 (MT-3) has been shown to protect against apoptotic neuronal death in the brains of patients with Alzheimer's disease. Zinc is a potent inhibitor of caspase-3 and its deficiency was found to promote apoptosis. Here, we measured the zinc and copper content in the brains of senescence-accelerated mouse/PRONE8 (SAMP8) and sought to investigate the effect of MT-3 on the apoptosis of neurons in the hippocampal CA1 region of these mice. METHOD: The zinc and copper content in the brain samples of SAMP8 and normal control SAMR1 mice were determined using an atomic absorption spectrophotometer. The mice were administered intraperitoneally for four weeks with MT-3 or MT1 and thereafter apoptosis was measured using the TUNEL method and the expression of anti-apoptotic protein Bcl-2 and proapoptotic protein Bax was examined by immunohistochemistry. RESULTS: Compared with that in SMAR1 mice, the content of zinc in the brains of SAMP8 mice was significantly reduced (P<0.05). Moreover, significant levels of apoptosis of neurons were observed in the hippocampus of SAMP8 mice, which, compared with those in SMAR1 mice, also showed significantly lower levels of Bcl-2 and higher levels of Bax (P<0.05). MT-3 increased zinc concentration in the hippocampus of SAMP8 mice and also significantly decreased apoptosis in these neurons dose-dependently and increased the levels of Bcl-2 and decreased the levels of Bax. CONCLUSION: MT-3 could attenuate apoptotic neuron death in the hippocampus of SAMP8, suggesting that the protein may lessen the development of neurodegeneration.


Subject(s)
Apoptosis/drug effects , Growth Inhibitors/pharmacology , Hippocampus/drug effects , Nerve Tissue Proteins/pharmacology , Neurons/drug effects , Aging , Animals , Brain Chemistry , Caspase 3/deficiency , Caspase Inhibitors , Copper/analysis , Hippocampus/metabolism , Hippocampus/pathology , Male , Metallothionein/pharmacology , Metallothionein 3 , Mice , Neurons/metabolism , Neurons/pathology , Proto-Oncogene Proteins c-bcl-2/analysis , Species Specificity , Zinc/analysis , Zinc/deficiency , bcl-2-Associated X Protein/analysis
5.
Arq. neuropsiquiatr ; 69(1): 105-111, Feb. 2011. ilus, tab
Article in English | LILACS | ID: lil-598355

ABSTRACT

OBJECTIVE: Metallothionein 3 (MT-3) has been shown to protect against apoptotic neuronal death in the brains of patients with Alzheimer's disease. Zinc is a potent inhibitor of caspase-3 and its deficiency was found to promote apoptosis. Here, we measured the zinc and copper content in the brains of senescence-accelerated mouse/PRONE8 (SAMP8) and sought to investigate the effect of MT-3 on the apoptosis of neurons in the hippocampal CA1 region of these mice. METHOD: The zinc and copper content in the brain samples of SAMP8 and normal control SAMR1 mice were determined using an atomic absorption spectrophotometer. The mice were administered intraperitoneally for four weeks with MT-3 or MT1 and thereafter apoptosis was measured using the TUNEL method and the expression of anti-apoptotic protein Bcl-2 and proapoptotic protein Bax was examined by immunohistochemistry. RESULTS: Compared with that in SMAR1 mice, the content of zinc in the brains of SAMP8 mice was significantly reduced (P<0.05). Moreover, significant levels of apoptosis of neurons were observed in the hippocampus of SAMP8 mice, which, compared with those in SMAR1 mice, also showed significantly lower levels of Bcl-2 and higher levels of Bax (P<0.05). MT-3 increased zinc concentration in the hippocampus of SAMP8 mice and also significantly decreased apoptosis in these neurons dose-dependently and increased the levels of Bcl-2 and decreased the levels of Bax. CONCLUSION: MT-3 could attenuate apoptotic neuron death in the hippocampus of SAMP8, suggesting that the protein may lessen the development of neurodegeneration.


OBJETIVO: Metalotioneína 3 (MT-3) tem mostrado proteção contra a apoptose neuronal em cérebros de pacientes com doença de Alzheimer. Zinco é um potente inibidor da caspase-3, e sua deficiência pode promover a apoptose. No presente trabalho, foram dosados os níveis de zinco e cobre nos cérebros de camundongos PRONE8 com envelhecimento acelerado (SAMP8), visando investigar o efeito da MT-3 na apoptse dos neurônios da região hipocampal CA1 destes camundongos. MÉTODO: Os níveis de zinco e cobre em amostras cerebrais de camundongos SAMP8 e de controles normais SAMR1 foram determinados por absorção atômica em espectrofotometria. Foram administradas MT-3 ou MT-1 intraperitoneais durante quatro semanas, sendo em seguida avaliada a apoptose pelo método TUNEL , enquanto a expressão da proteína anti-apoptótica Bcl-2 e a proteína pró-apoptótica Bax foram avaliadas por imunohistoquímica. RESULTADOS: Em comparação aos camundongos SMAR1, o nível de zinco nas amostras cerebrais dos camundongos SAMP8 estava significativamente diminuído (P<0.05). Além disto, níveis significativos de apoptose foram observados no hipocampo dos camundongos SAMP8, o que, em comparação com os níveis em camundongos SMAR1, também mostrava níveis significativamente mais baixos de Bcl-2 e níveis mais altos de Bax (P<0.05). MT-3 aumentou a concentração de zinco no hipocampo dos camundongos SAMP8, além de diminuir significativamente a apoptose destes neurônios, de uma forma dose-dependente, ao mesmo tempo que aumentou níveis de Bcl-2 e diminuiu níveis de Bax. CONCLUSÃO: MT-3 pode atenuar a morte neuronal apoptótica no hipocampo de SAMP8, o que sugere que esta proteína possa diminuir a neurodegeneração.


Subject(s)
Animals , Male , Mice , Apoptosis/drug effects , Growth Inhibitors/pharmacology , Hippocampus/drug effects , Nerve Tissue Proteins/pharmacology , Neurons/drug effects , Aging , Brain Chemistry , /antagonists & inhibitors , /deficiency , Copper/analysis , Hippocampus/metabolism , Hippocampus/pathology , Metallothionein/pharmacology , Neurons/metabolism , Neurons/pathology , /analysis , Species Specificity , Zinc/analysis , Zinc/deficiency , /analysis
SELECTION OF CITATIONS
SEARCH DETAIL